Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.

Levanon K, Sapoznik S, Bahar-Shany K, Brand H, Shapira-Frommer R, Korach J, Hirsch MS, Roh MH, Miron A, Liu JF, Vena N, Ligon AH, Fotheringham S, Bailey D, Flavin RJ, Birrer MJ, Drapkin RI.

Oncogene. 2014 Aug 28;33(35):4424-32. doi: 10.1038/onc.2013.394. Epub 2013 Sep 30.

2.

Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.

Jazaeri AA, Bryant JL, Park H, Li H, Dahiya N, Stoler MH, Ferriss JS, Dutta A.

Neoplasia. 2011 Oct;13(10):899-911.

3.

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.

Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1891.

PMID:
20861711
4.

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.

Karst AM, Jones PM, Vena N, Ligon AH, Liu JF, Hirsch MS, Etemadmoghadam D, Bowtell DD, Drapkin R.

Cancer Res. 2014 Feb 15;74(4):1141-52. doi: 10.1158/0008-5472.CAN-13-2247. Epub 2013 Dec 23.

5.

[Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].

Xiang L, Li J, Wang LJ, Zheng WX, Kong BH.

Zhonghua Fu Chan Ke Za Zhi. 2011 Oct;46(10):729-35. Chinese.

PMID:
22321344
6.

Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.

Ahmed N, Abubaker K, Findlay J, Quinn M.

J Cell Biochem. 2013 Jan;114(1):21-34. doi: 10.1002/jcb.24317. Review.

PMID:
22887554
7.

[Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].

Guo DH, Pang SJ, Shen Y, Li Y.

Zhonghua Zhong Liu Za Zhi. 2011 Apr;33(4):287-90. Chinese.

PMID:
21575501
8.

MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.

Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijn M, Gilks CB.

PLoS One. 2009 Oct 2;4(10):e7314. doi: 10.1371/journal.pone.0007314.

9.

Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.

Maeda D, Ota S, Takazawa Y, Ohashi K, Mori M, Imamura T, Nakagawa S, Yano T, Taketani Y, Fukayama M.

Virchows Arch. 2010 Nov;457(5):597-608. doi: 10.1007/s00428-010-0979-4. Epub 2010 Sep 25.

PMID:
20872013
10.

[Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].

Liang Y, Chen XD, Lü BJ, Zhou CY, Zhang XF, Shi HY.

Zhonghua Fu Chan Ke Za Zhi. 2011 Oct;46(10):724-8. Chinese.

PMID:
22321343
11.

New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Levanon K, Crum C, Drapkin R.

J Clin Oncol. 2008 Nov 10;26(32):5284-93. doi: 10.1200/JCO.2008.18.1107. Epub 2008 Oct 14. Review.

12.

Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.

Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D.

Gynecol Oncol. 2008 Sep;110(3):408-17. doi: 10.1016/j.ygyno.2008.05.010. Epub 2008 Jul 1.

PMID:
18597838
13.

[Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].

Zhang Q, He XJ, Ma LP, Li N, Yang J, Cheng YX, Cui H.

Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):885-90. Chinese.

PMID:
22340095
14.

High-grade serous ovarian cancer arises from fallopian tube in a mouse model.

Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3921-6. doi: 10.1073/pnas.1117135109. Epub 2012 Feb 13.

15.

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

Della Pepa C, Tonini G, Santini D, Losito S, Pisano C, Di Napoli M, Cecere SC, Gargiulo P, Pignata S.

Cancer Treat Rev. 2015 Feb;41(2):136-43. doi: 10.1016/j.ctrv.2014.12.003. Epub 2014 Dec 23. Review.

PMID:
25573350
16.

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Vang R, Shih IeM, Kurman RJ.

Histopathology. 2013 Jan;62(1):44-58. doi: 10.1111/his.12046. Review.

PMID:
23240669
17.

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

McCluggage WG.

Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Review.

PMID:
21716157
18.

Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.

Lassus H, Laitinen MP, Anttonen M, Heikinheimo M, Aaltonen LA, Ritvos O, Butzow R.

Lab Invest. 2001 Apr;81(4):517-26.

PMID:
11304571
19.

[The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].

Chêne G, Dauplat J, Radosevic-Robin N, Cayre A, Penault-Llorca F.

Bull Cancer. 2013 Jul-Aug;100(7-8):757-64. doi: 10.1684/bdc.2013.1785. French.

PMID:
23831931
20.

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.

Karst AM, Levanon K, Drapkin R.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7547-52. doi: 10.1073/pnas.1017300108. Epub 2011 Apr 18.

Items per page

Supplemental Content

Write to the Help Desk